Four weeks ago, after a Houston judge denied J&J’s third attempt to resolve approximately 90,000 talcum powder lawsuits ...

Johnson & Johnson's dividend yield is currently ... 10% potential upside from the current stock price. On April 15, the company announced its Q1 2025 earnings, posting adjusted EPS of $2.77 ...

In other recent news, Johnson & Johnson reported significant developments across various medical treatments and financial strategies. The company announced promising results from its Phase 3 ...

With a market cap of $372.9 billion, Johnson & Johnson (JNJ) is a global healthcare leader with a robust and diversified business model spanning pharmaceuticals, medical technologies, and ...

Inc., a Johnson & Johson company. 5 ICONIC-LEAD (NCT06095115) is a randomized controlled trial (RCT) to evaluate the efficacy and safety of icotrokinra compared with placebo in participants with ...

Company seeks approval for new schedules to improve patient convenience Janssen-Cilag International NV, a Johnson & Johnson company, has submitted an application to the European Medicines Agency (EMA) ...

American Healthcare giant Johnson & Johnson’s eye health arm, J&J Vision is preparing a pipeline of India-specific ...

Johnson company, to enhance early detection of lung cancer in India. This collaboration brings together cutting-edge AI and medical technology, helping identify lung cancer at its most treatable ...